Fabrication and characterization of the H/J-type aggregates astaxanthin/bovine serum albumin/chitosan nanoparticles. 2022

Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
College of Biological Engineering, Henan University of Technology, Zhengzhou 450001, PR China; Laboratory of Nutritional Biochemistry, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan. Electronic address: yyzhao2009@outlook.com.

Astaxanthin is a natural liposoluble ketocarotenoid with various biological activities. Hydrophobic astaxanthin with C2h symmetry can self-assembly form H-type aggregates and J-type aggregates in hydrated polar solvents. However, astaxanthin and its aggregates are limited by its water insolubility and chemical instability. Here, the biological macromolecules bovine serum albumin (BSA) and chitosan were chosen as protein-polysaccharides based delivery systems for astaxanthin aggregates by molecular self-assembly method. The precise prepared H-ABC-NPs and J-ABC-NPs suspensions were both near spheres with hydrodynamic size around 281 ± 9 nm and 368 ± 5 nm and zeta potentials around +26 mV and +30 mV, respectively. Two types of astaxanthin aggregates were distinguished, water-dispersible, and stable in nanocarriers through UV-vis spectra observation. The encapsulation efficiency of the astaxanthin in ABC-NPs was above 90 %. Fourier transform infrared spectroscopy (FTIR) and circular dichroism (CD) analyses indicated that the dominant driving forces of ABC-NPs formation mainly included electrostatic, hydrophobic interactions and hydrogen bonding. These results offer an elegant opportunity for the protein-polysaccharides delivery systems, and provide an important perspective for applying novel water-dispersed astaxanthin aggregates products in nutrition and medicine industry.

UI MeSH Term Description Entries
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D012710 Serum Albumin, Bovine Serum albumin from cows, commonly used in in vitro biological studies. (From Stedman, 25th ed) Fetal Bovine Serum,Fetal Calf Serum,Albumin Bovine,Bovine Albumin,Bovine Serum Albumin,Albumin, Bovine,Albumin, Bovine Serum,Bovine Serum, Fetal,Bovine, Albumin,Calf Serum, Fetal,Serum, Fetal Bovine,Serum, Fetal Calf
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide
D048271 Chitosan Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS. Poliglusam
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
January 2012, Journal of Wuhan University of Technology. Materials science edition,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
July 2013, International journal of biological macromolecules,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
February 2016, Journal of nanoscience and nanotechnology,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
September 2022, Colloids and surfaces. B, Biointerfaces,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
January 2018, Food chemistry,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
January 2024, Current drug delivery,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
March 2007, Journal of microencapsulation,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
October 2022, Molecules (Basel, Switzerland),
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
August 2014, International journal of biological macromolecules,
Yingyuan Zhao, and Junxia Liu, and Shengmeng Zhang, and Zhaoxuan Wang, and Huihui Jia, and Hiroaki Oda, and Ruifang Li
November 2017, Carbohydrate polymers,
Copied contents to your clipboard!